Sunhawk Vision Biotech (ROCO:7759) Preferred Stock: NT$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7759 Sunhawk Vision Biotech Inc ROCO:7759
20 GF Score
Price NT$30.45
! 1 Warning Sign
View Full Analysis

What is Sunhawk Vision Biotech Preferred Stock?

Sunhawk Vision Biotech ROCO:7759 -0.16% 20 Preferred Stock is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:7759 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Preferred stock is a special equity security that has properties of both equity and debt. Sunhawk Vision Biotech's preferred stock for the quarter that ended in Jun. 2026 was NT$0.00 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. Sunhawk Vision Biotech's Enterprise Value for the quarter that ended in Jun. 2026 was NT$1,756.92 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. Sunhawk Vision Biotech's Book Value per Share for the quarter that ended in Jun. 2026 was NT$5.94.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). Sunhawk Vision Biotech's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was NT$-0.77.


Sunhawk Vision Biotech  (ROCO:7759) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

Sunhawk Vision Biotech's Enterprise Value for the quarter that ended in Jun. 2026 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

Sunhawk Vision Biotech's Book Value per Share for the quarter that ended in Jun. 2026 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

Sunhawk Vision Biotech's Earnings per Share (Diluted) (EPS) for the six months ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunhawk Vision Biotech Preferred Stock Related Terms


Sunhawk Vision Biotech Preferred Stock Historical Data

* Premium members only.

The historical data trend for Sunhawk Vision Biotech's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunhawk Vision Biotech Preferred Stock Chart

Sunhawk Vision Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sunhawk Vision Biotech Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7759
20GF Score
Sunhawk Vision Biotech Inc ROCO:7759
Preferred Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunhawk Vision Biotech Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.

Frequently Asked Questions Learn more about Preferred Stock →
What does a Preferred Stock of NT$0.00 Mil mean?
Sunhawk Vision Biotech (ROCO:7759) has a Preferred Stock of NT$0.00 Mil as of Jun. 2026. Preferred Stock represents the par value of a company's preferred shares. View historical data on Sunhawk Vision Biotech and its competitors.
Is Sunhawk Vision Biotech's Preferred Stock too high?
Sunhawk Vision Biotech's current Preferred Stock is NT$0.00 Mil. Overall, Sunhawk Vision Biotech has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's Preferred Stock compare to VRTX and REGN?
Sunhawk Vision Biotech's Preferred Stock of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Stock for a Biotechnology company?
A good Preferred Stock depends on the Biotechnology industry context. However, Preferred Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Stock mean?
A high Preferred Stock can signal that a stock is expensive relative to its fundamentals. Preferred Stock represents the par value of a company's preferred shares. View historical data on Sunhawk Vision Biotech and its competitors. Sunhawk Vision Biotech's current Preferred Stock is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current Preferred Stock of NT$0.00 Mil. The current Preferred Stock is NT$0.00 Mil. Sunhawk Vision Biotech's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Stock calculated?
Preferred Stock is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current Preferred Stock is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunhawk Vision Biotech Business Description

Address No. 6 Siwei 3rd Road, 17th Floor, Room A1, Lingya District, Kaohsiung, TWN
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
20GF Score

Get the complete analysis for ROCO:7759

Preferred Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.45
Price